Medipal Holdings P Stock Fundamentals
59Z Stock | EUR 14.10 0.10 0.70% |
MEDIPAL HOLDINGS P fundamentals help investors to digest information that contributes to MEDIPAL HOLDINGS's financial success or failures. It also enables traders to predict the movement of MEDIPAL Stock. The fundamental analysis module provides a way to measure MEDIPAL HOLDINGS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MEDIPAL HOLDINGS stock.
MEDIPAL |
MEDIPAL HOLDINGS P Company Shares Outstanding Analysis
MEDIPAL HOLDINGS's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current MEDIPAL HOLDINGS Shares Outstanding | 209.96 M |
Most of MEDIPAL HOLDINGS's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MEDIPAL HOLDINGS P is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, MEDIPAL HOLDINGS P has 209.96 M of shares currently outstending. This is 16.3% higher than that of the Healthcare sector and 38.9% higher than that of the Medical Distribution industry. The shares outstanding for all Germany stocks is 63.28% higher than that of the company.
MEDIPAL HOLDINGS P Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MEDIPAL HOLDINGS's current stock value. Our valuation model uses many indicators to compare MEDIPAL HOLDINGS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MEDIPAL HOLDINGS competition to find correlations between indicators driving MEDIPAL HOLDINGS's intrinsic value. More Info.MEDIPAL HOLDINGS P is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.27 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for MEDIPAL HOLDINGS P is roughly 3.71 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MEDIPAL HOLDINGS's earnings, one of the primary drivers of an investment's value.MEDIPAL Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MEDIPAL HOLDINGS's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MEDIPAL HOLDINGS could also be used in its relative valuation, which is a method of valuing MEDIPAL HOLDINGS by comparing valuation metrics of similar companies.MEDIPAL HOLDINGS is currently under evaluation in shares outstanding category among its peers.
MEDIPAL Fundamentals
Return On Equity | 0.0597 | |||
Return On Asset | 0.0161 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.01 % | |||
Shares Outstanding | 209.96 M | |||
Shares Owned By Insiders | 9.02 % | |||
Shares Owned By Institutions | 28.77 % | |||
Price To Earning | 17.52 X | |||
Revenue | 3.35 T | |||
Gross Profit | 217.44 B | |||
EBITDA | 60.12 B | |||
Net Income | 26.47 B | |||
Cash And Equivalents | 230.57 B | |||
Total Debt | 30.36 B | |||
Debt To Equity | 0.05 % | |||
Current Ratio | 1.23 X | |||
Book Value Per Share | 2,636 X | |||
Cash Flow From Operations | 34.45 B | |||
Earnings Per Share | 0.89 X | |||
Number Of Employees | 12.8 K | |||
Beta | 0.26 | |||
Market Capitalization | 2.57 B | |||
Annual Yield | 0.03 % | |||
Last Dividend Paid | 23.0 |
About MEDIPAL HOLDINGS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDIPAL HOLDINGS P's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIPAL HOLDINGS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIPAL HOLDINGS P based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business. The company was founded in 1898 and is headquartered in Tokyo, Japan. MEDIPAL HOLDINGS operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12971 people.
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Other Information on Investing in MEDIPAL Stock
MEDIPAL HOLDINGS financial ratios help investors to determine whether MEDIPAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDIPAL with respect to the benefits of owning MEDIPAL HOLDINGS security.